Persistent Posttreatment Fatigue in Thyroid Cancer Survivors: A Scoping Review

• Autores: Anna M. Sawka, Asima Naeem, Jennifer Jones, Julia Lowe, Philip Segal, Jeannette Goguen, Jeremy Gilbert, Afshan Zahedi, Catherine Kelly, Shereen Ezzat
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 43, Nº. 2, 2014 (Ejemplar dedicado a: Thyroid Cancer and Other Thyroid Disorders), págs. 475-494
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The relevance of persistent posttreatment fatigue (PPF) to thyroid cancer (TC) survivor populations is not known. This article presents a scoping review, which is an overview of published research activity. Uncontrolled data suggest that PPF is one of the most common complaints in TC survivors. Furthermore, statistically significantly worse levels of fatigue were reported in TC survivors, compared with the general population or healthy controls. There was some inconsistency among PPF risk factors. More research is needed on PPF in TC survivors, including long-term prospective cohort studies, research on fatigue severity prevalence, and randomized controlled trials of treatment strategies.